Investigator-initiated, open-label trial of ustekinumab for the treatment of moderate-to-severe palmoplantar psoriasis

By Au Shiu-Chung  

Journal of Dermatological Treatment, Vol. 24, Iss. 3, 2013-06 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Safety and Efficacy of a Milk-derived Extract in the Treatment of Plaque Psoriasis:An Open-label Study

By Poulin Y.   Pouliot Y.   Lamiot E.   Aattouri N.   Gauthier S.  

Journal of Cutaneous Medicine and Surgery, Vol. 9, Iss. 6, 2005-12 ,pp. : 271-275

Springer Publishing Company

Access to resources Recommend Favorite

0.3% Tacrolimus Gel and 0.5% Tacrolimus Cream Show Efficacy in Mild to Moderate Plaque Psoriasis: Results of a Randomized, Open-label, Observer-blinded Study

By Ortonne Jean-Paul   van de Kerkhof Peter C. M.   Prinz Jörg C.   Bieber Thomas   Lahfa Morad   Rubins Andris   Wozel Gottfried      

Acta Dermato-Venereologica, Vol. 86, Iss. 1, 2006-01 ,pp. : 29-33

Medical Journals Limited

Access to resources Recommend Favorite

Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

By Vena Gino A.   Galluccio Antonia   Pezza Michele   Vestita Michelangelo   Cassano Nicoletta  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 255-260

Informa Healthcare

Access to resources Recommend Favorite

Psoriasis responds to intralesional injections of alefacept and may predict systemic response to intramuscular alefacept: Interim results of a single-arm, open-label study

By Gattu Shilpa   Busse Kristine   Bhutani Tina   Chiang Charles   Nguyen Thao   Becker Emily   Koo John Y. M.  

Journal of Dermatological Treatment, Vol. 23, Iss. 2, 2012-04 ,pp. : 103-108

Informa Healthcare

Access to resources Recommend Favorite